⌘K

Login Start Free

Home/Filings/4/0000899243-23-004595

4//SEC Filing

Katz Barrett 4

Accession 0000899243-23-004595

CIK 0001590750other

View on SEC.gov Company Profile

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 4:54 PM ET

Size

5.8 KB

Accession

0000899243-23-004595

Insider Transaction Report

Form 4

Period: 2023-02-08

Viridian Therapeutics, Inc.\DEVRDN

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2023-02-08+108,000→ 108,000 total
Exercise: $34.20Exp: 2033-02-08→ Common Stock (108,000 underlying)

Footnotes (1)

[F1]The option vests in equal monthly installments through February 8, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother

Related Parties

1

filerCIK 0001841628

Filing Metadata

Form type: 4
Filed: Feb 9, 7:00 PM ET
Accepted: Feb 10, 4:54 PM ET
Size: 5.8 KB

View on SEC.gov